What is Lyophilisation? How Research Peptides Are Freeze-Dried

If you have ever ordered a research peptide, you will have received it as a lyophilised powder — a dry, often fluffy or cake-like substance in a sealed glass vial. But why are research peptides supplied this way rather than as ready-to-use solutions? And what exactly is lyophilisation? This guide explains the science behind freeze-drying and why it is the standard for research peptide supply.

What is Lyophilisation?

Lyophilisation — also called freeze-drying — is a preservation process that removes water from a substance by first freezing it and then reducing the surrounding pressure to allow the ice to sublimate (convert directly from solid ice to water vapour, bypassing the liquid phase). The result is a dry, stable powder that retains the chemical structure of the original compound.

The word lyophilisation comes from the Greek words for "solvent-loving" — reflecting the fact that the compound retains an affinity for the solvent (water) it was dissolved in and can be reconstituted easily.

The Three Stages of Lyophilisation

Stage 1: Freezing. The peptide solution is rapidly cooled to below its eutectic point — typically -40°C to -80°C. Rapid freezing is important: it creates smaller ice crystals that cause less mechanical damage to the peptide's structure and produce a more uniform lyophilised cake.

Stage 2: Primary drying (sublimation). The pressure in the lyophiliser is reduced to below the vapour pressure of ice (typically below 0.1 mbar), and the product is gently warmed. Under these conditions, ice sublimes directly to water vapour without passing through the liquid phase. This removes approximately 90-95% of the water content and is the longest stage.

Stage 3: Secondary drying (desorption). After primary drying, some water molecules remain bound to the peptide structure through hydrogen bonding. Secondary drying raises the temperature further (typically 20-30°C) to desorb this bound water, reducing the final moisture content to below 1-3%. This very low residual moisture is what gives lyophilised peptides their long stability.

Why Lyophilisation Dramatically Improves Peptide Stability

Water is the enemy of peptide stability in two main ways.

Hydrolysis. In aqueous solution, water molecules attack and break peptide bonds — cleaving the protein backbone into smaller fragments. This is an ongoing chemical reaction whose rate depends on temperature and pH. Even at 4°C, hydrolytic degradation proceeds at measurable rates in aqueous peptide solutions.

Microbial growth. Liquid solutions support bacterial and fungal growth. Unless preserved with antimicrobial agents (like the benzyl alcohol in bacteriostatic water), aqueous peptide solutions can become contaminated within days.

By removing water, lyophilisation essentially halts both hydrolysis and microbial growth. The resulting powder is stable at -20°C for 2-3 years for most research peptides — far longer than any aqueous solution.

The Lyophilised Cake: What Researchers See

When you open a lyophilised peptide vial, you may see one of several presentations depending on how the product was manufactured.

Fluffy or cottony white powder. Produced when the frozen solution was rapidly dried. Fine particles with high surface area — reconstitutes very quickly.

Dense white cake. Produced when the frozen solution was dried more slowly. A cake that fills the bottom of the vial and may have cracked during the drying process. Reconstitutes more slowly but is equally potent.

Small pellet or plug. Some lyophilisation protocols produce a compact pellet. Normal and fully potent.

All of these presentations are normal. The appearance of the lyophilised cake does not indicate quality — only HPLC purity data from the certificate of analysis can confirm peptide integrity.

Excipients in Lyophilised Peptides

Some peptide manufacturers add excipients (bulking agents, cryoprotectants, or stabilisers) to their lyophilised preparations. Common excipients include mannitol, lactose, trehalose, and glycine. These help the cake maintain its structure during drying and may improve long-term stability.

Excipients add mass to the vial. If a 5mg vial contains excipients, not all 5mg is the active peptide. Signal Labs supplies peptides at stated concentrations of active compound verified by HPLC — always check your certificate of analysis for details on excipient content.

From Lyophilisation to Laboratory Use

The lyophilised peptide must be reconstituted — dissolved in an appropriate solvent — before use in laboratory research. This process is covered in detail in our reconstitution guide.

Key points to remember about lyophilised peptides:

Equilibrate the vial to room temperature before opening to prevent condensation from entering. Reconstitute gently — add solvent slowly down the side of the vial and swirl rather than vortex. Aliquot reconstituted solutions immediately to avoid repeated freeze-thaw cycles. Store unused lyophilised peptide back at -20°C promptly.

HPLC Purity and the Certificate of Analysis

All Signal Labs research peptides are supplied at greater than or equal to 98% purity as verified by HPLC (high-performance liquid chromatography). The certificate of analysis (CoA) for each batch confirms identity, purity, and water content. If you need a CoA for a specific batch, contact our support team with your batch number.

For laboratory and analytical research purposes only. Not for human or veterinary use. No dosage or administration guidance is provided or implied.

Reconstitution guide | Storage and stability guide | Powder appearance guide

The Physics of Lyophilisation: Why Ice Sublimes

The phase diagram of water explains why lyophilisation works. At standard atmospheric pressure (101.3 kPa), water transitions between ice, liquid, and vapour as temperature changes. But at pressures below the triple point pressure (611 Pa, approximately 0.006 atm), liquid water cannot exist — ice passes directly to vapour without going through the liquid phase. This is sublimation.

Lyophilisers reduce chamber pressure to approximately 100-500 mPa (0.001-0.005 atm) — well below the triple point pressure — while maintaining the product frozen. Under these conditions, ice in the frozen peptide solution sublimes directly to water vapour, which is drawn away by the vacuum system and condensed on refrigerated collector coils. The peptide structure is preserved in the solid state throughout, preventing the hydrolytic damage that would occur if the material passed through a liquid phase.

Industrial Lyophilisation vs Laboratory-Scale

Industrial pharmaceutical lyophilisation uses large-scale freeze-dryers with controlled shelf temperatures, precise pressure profiles, and validated cycle parameters. Pharmaceutical-grade lyophilisation cycles include formal validation of shelf temperature uniformity, condenser capacity, and residual moisture specifications. This is the standard for drug product manufacturing.

Research-grade lyophilisation for peptides uses smaller bench-top or pilot-scale freeze-dryers. The principles are identical, but cycle optimisation is less formal. Key parameters controlled in research lyophilisation include: initial freezing temperature and rate (affects ice crystal size and lyophilised cake structure), primary drying shelf temperature and pressure (determines sublimation rate), secondary drying temperature and duration (determines final moisture content), and backfill gas (typically nitrogen to prevent oxidation during vial stoppering).

Formulation Chemistry: Excipients and Cryoprotectants

Most pharmaceutical lyophilised peptides include excipients — small molecules added to the formulation that improve the lyophilisation process and product stability. Common excipients include:

Bulking agents (mannitol, glycine, lactose) — provide physical structure to the lyophilised cake, preventing collapse. Without bulking agents, low-concentration peptide solutions may not form a robust cake and can produce an amorphous powder that is difficult to handle.

Cryoprotectants (sucrose, trehalose, mannitol) — protect the peptide during freezing by forming a glassy matrix that prevents ice crystal formation adjacent to the peptide, which can cause mechanical stress-induced degradation. Sucrose is the most widely used pharmaceutical cryoprotectant.

Buffer salts (phosphate, citrate, acetate) — maintain the desired pH of the reconstituted solution. The choice of buffer is critical: phosphate buffers can concentrate and crystallise during freezing, causing pH shifts that may degrade acid- or base-sensitive peptides.

Signal Labs peptides are lyophilised to pharmaceutical standards. Certificates of analysis specify residual moisture content, confirming successful removal of water to the target level required for long-term stability at -20°C.

Quality Assessment of Lyophilised Peptides

Visual inspection is the first quality check — the lyophilised cake or powder should have consistent appearance (colour, texture, absence of collapse or meltback), and the vial should show no signs of moisture ingress (which would manifest as a wet or discoloured cake).

Residual moisture analysis by Karl Fischer titration or thermogravimetric analysis (TGA) confirms water content below the stability threshold (typically below 1-3% for most peptides).

HPLC purity analysis confirms that the lyophilisation process itself did not cause chemical degradation — the purity chromatogram of the lyophilised product should match the pre-lyophilisation solution within method precision.

Reconstitution behaviour — how readily the lyophilised product dissolves in the specified reconstitution solvent — provides a practical quality indicator. A well-lyophilised peptide should dissolve rapidly with gentle swirling, producing a clear solution at the expected colour.

Published Research References